Free Trial

Verastem (VSTM) News Today

Verastem logo
$6.40 -0.17 (-2.59%)
Closing price 04:00 PM Eastern
Extended Trading
$6.42 +0.02 (+0.39%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Verastem (NASDAQ:VSTM) Upgraded to Hold at StockNews.com
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Upgraded to "Hold" at StockNews.com
StockNews.com raised Verastem from a "sell" rating to a "hold" rating in a research note on Monday.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Price Target Raised to $14.00
Guggenheim increased their price objective on Verastem from $13.00 to $14.00 and gave the company a "buy" rating in a report on Monday.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Given New $10.00 Price Target at HC Wainwright
HC Wainwright raised their price target on shares of Verastem from $7.00 to $10.00 and gave the stock a "buy" rating in a research report on Monday.
Verastem price target raised to $14 from $13 at Guggenheim
Verastem CFO Daniel Calkins sells shares worth $630
Verastem price target raised to $10 from $7 at H.C. Wainwright
Verastem, Inc. stock logo
Rosalind Advisors Inc. Takes Position in Verastem, Inc. (NASDAQ:VSTM)
Rosalind Advisors Inc. purchased a new stake in Verastem, Inc. (NASDAQ:VSTM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 900,000 shares of the biopharmaceutical company's stock, valued at approximat
Alliance Global Partners Remains a Buy on Verastem (VSTM)
Verastem, Inc. stock logo
Royal Bank of Canada Has Lowered Expectations for Verastem (NASDAQ:VSTM) Stock Price
Royal Bank of Canada dropped their price target on shares of Verastem from $16.00 to $14.00 and set an "outperform" rating for the company in a research note on Friday.
BTIG Sticks to Its Buy Rating for Verastem (VSTM)
Verastem price target lowered to $14 from $16 at RBC Capital
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Issues Quarterly Earnings Results
Verastem (NASDAQ:VSTM - Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by ($0.57).
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Announces Quarterly Earnings Results
Verastem (NASDAQ:VSTM - Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.33) earnings per share for the quarter, missing analysts' consensus estimates of ($0.76) by ($0.57).
Verastem reports Q4 EPS (60c), consensus (74c)
Verastem files to sell 1.42M shares of common stock for holders
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Buy" from Brokerages
Shares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have been assigned an average recommendation of "Buy" from the nine ratings firms that are currently covering the company, Marketbeat reports. Nine analysts have rated the stock with a buy rating. The average 12 month target price among brok
Verastem CEO sells shares worth $1,695
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving Average - Here's Why
Verastem (NASDAQ:VSTM) Stock Crosses Above Two Hundred Day Moving Average - What's Next?
Verastem: Upcoming PDUFA, But I Remain Cautious
Verastem, Inc. stock logo
Verastem (VSTM) to Release Quarterly Earnings on Thursday
Verastem (NASDAQ:VSTM) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.
Verastem, Inc. stock logo
Verastem (VSTM) Expected to Announce Earnings on Thursday
Verastem (NASDAQ:VSTM) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Stock Price Passes Above 200 Day Moving Average - Should You Sell?
Verastem (NASDAQ:VSTM) Share Price Passes Above 200 Day Moving Average - Should You Sell?
Verastem, Inc. stock logo
Verastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of "Buy" by Brokerages
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) has been given a consensus recommendation of "Buy" by the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 12 month price objective am
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Share Price Crosses Above 200-Day Moving Average - What's Next?
Verastem (NASDAQ:VSTM) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Verastem price target raised to $9 from $7 at B. Riley
Verastem, Inc. stock logo
B. Riley Issues Positive Forecast for Verastem (NASDAQ:VSTM) Stock Price
B. Riley raised their price objective on Verastem from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Friday.
Verastem, Inc. stock logo
Short Interest in Verastem, Inc. (NASDAQ:VSTM) Increases By 59.5%
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,930,000 shares, a growth of 59.5% from the December 31st total of 3,090,000 shares. Approximately 12.5% of the shares of the company are short sold. Based on an average daily volume of 1,480,000 shares, the short-interest ratio is presently 3.3 days.
Mizuho Securities Sticks to Its Buy Rating for Verastem (VSTM)
Verastem, Inc. stock logo
Verastem (NASDAQ:VSTM) Earns "Buy" Rating from Guggenheim
Guggenheim reissued a "buy" rating on shares of Verastem in a research report on Friday.
Verastem Inches up on ’25 Lookahead
Verastem, Inc. stock logo
Cantor Fitzgerald Forecasts Verastem FY2025 Earnings
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Verastem in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the biopharmaceutical company w
Remove Ads
Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.

VSTM Media Mentions By Week

VSTM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VSTM
News Sentiment

0.27

0.89

Average
Medical
News Sentiment

VSTM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VSTM Articles
This Week

30

4

VSTM Articles
Average Week

Remove Ads
Get Verastem News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSTM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VSTM) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners